EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Advancements and Innovative Strategies in Induced Pluripotent Stem Cell‐Derived Mesenchymal Stem Cell Therapy: A Comprehensive Review

Xiaoyu Shi, Kun Zhang, Fengshi Yu, Qi Qi, Xiaoyu Cai, Yu Zhang iD

Stem Cells International · 2024-01 · 2024 (1)

DOI: 10.1155/2024/4073485 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Stem Cells International, online erschienen am 30.09.2024. Verfasst von Xiaoyu Shi und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Industrial Base for Stem Cell Engineering Products, Tianjin 300384, China. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 84 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The effectiveness and safety of mesenchymal stem cell (MSC) therapy have been substantiated across various diseases. Nevertheless, challenges such as the restricted in vitro expansion capacity of tissue‐derived MSCs and the clinical instability due to the high heterogeneity of isolated cells require urgent resolution. The induced pluripotent stem cell‐derived MSCs (iPSC‐MSCs), which is differentiated from iPSCs via specific experimental pathways, holds considerable potential as a substitute for tissue derived MSCs. Multiple studies have demonstrated that iPSCs can be differentiated into iPSC‐MSCs through diverse differentiation strategies. Research suggests that iPSC‐MSCs, when compared to tissue derived MSCs, exhibit superior characteristics in terms of proliferation ability, immune modulation capacity, and biological efficiency. In this review, we meticulously described and summarized the experimental methods of iPSC differentiation into iPSC‐MSCs, the application of iPSC‐MSCs in various disease models, the latest advancements in clinically relevant iPSC‐derived cell products, and the development strategies for the next generation of iPSC‐derived therapy products (not only cell products but also their derivatives).

Autor:innen und Institutionen

  • State Industrial Base for Stem Cell Engineering Products, Tianjin 300384, China.
  • VCANBIO Cell and Gene Engineering Corp. Ltd., Tianjin, China.

ORCID-Profile: Yu Zhang

Zitieren

APA

Shi, X., Zhang, K., Yu, F., Qi, Q., Cai, X., & Zhang, Y. (2024). Advancements and Innovative Strategies in Induced Pluripotent Stem Cell‐Derived Mesenchymal Stem Cell Therapy: A Comprehensive Review. Stem Cells International, 2024(1). https://doi.org/10.1155/2024/4073485

Vancouver

Shi X, Zhang K, Yu F, Qi Q, Cai X, Zhang Y. Advancements and Innovative Strategies in Induced Pluripotent Stem Cell‐Derived Mesenchymal Stem Cell Therapy: A Comprehensive Review. Stem Cells International. 2024;2024(1). doi:10.1155/2024/4073485

BibTeX
@article{Shi2024,
  author = {Shi, Xiaoyu and Zhang, Kun and Yu, Fengshi and Qi, Qi and Cai, Xiaoyu and Zhang, Yu},
  title = {Advancements and Innovative Strategies in Induced Pluripotent Stem Cell‐Derived Mesenchymal Stem Cell Therapy: A Comprehensive Review},
  journal = {Stem Cells International},
  year = {2024},
  volume = {2024},
  number = {1},
  doi = {10.1155/2024/4073485}
}
Kostenlos starten →